Return to homepagePandemic Pact

Cellular Immune Phenotype in Patients with Severe COVID Disease Before and After COVID-19 Treatment Dr. Lisa Barrett Nova Scotia Health, Dalhousie University Total Project Value: $75,000 Funding Partners: Nova Scotia Health Research Coalition, Nova Scotia Health, Dalhousie University, Dalhousie Medical Research Foundation (DMRF), QEII Health Sciences Centre Foundation, IWK Foundation, IWK Health Centre, Dartmouth General Hospital Foundation (DGHF) Key Words: COVID-19, immune disruption, reversibility, dysregulation, therapy https://www.youtube.com/watch?v=q1IQq0CZtyY https://dmrf.ca/molly-appeal/

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2021

  • Funder

    Research Nova Scotia

  • Principal Investigator

    Dr. Lisa Barrett

  • Research Location

    N/A

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen morphology, shedding & natural history

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

COVID-19, immune disruption, reversibility, dysregulation, therapy